Back to Search
Start Over
Omalizumab as a Succesfull Therapy in Normocomplementemic Urticarial Vasculitis: A Series of Four Patients and Review of the Literature.
- Source :
-
Annals of dermatology [Ann Dermatol] 2019 Jun; Vol. 31 (3), pp. 335-338. Date of Electronic Publication: 2019 May 01. - Publication Year :
- 2019
-
Abstract
- Urticarial vasculitis is an eruption characterized by inflamed itchy or painful red papules or plaques that resemble urticaria but last longer than 24 hours and heal with residual pigmentation or purpura. Histopathologically, urticarial vasculitis presents as leukocytoclastic vasculitis with perivascular infiltrate and fibrin deposits. The treatment options are oral antihistamines, oral corticosteroids, dapsone, colchicine and hydroxychloroquine. We report four cases with normocomplementemic urticarial vasculitis who were treated with omalizumab and a brief review of the literature on the use of omalizumab in normocomplementemic urticarial vasculitis.<br />Competing Interests: CONFLICTS OF INTEREST: The authors have nothing to disclose.<br /> (Copyright © 2019 The Korean Dermatological Association and The Korean Society for Investigative Dermatology.)
Details
- Language :
- English
- ISSN :
- 2005-3894
- Volume :
- 31
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Annals of dermatology
- Publication Type :
- Report
- Accession number :
- 33911601
- Full Text :
- https://doi.org/10.5021/ad.2019.31.3.335